Cholinesterase inhibitors as Alzheimer's therapeutics (Review).

Volume: 20, Issue: 2, Pages: 1479 - 1487
Published: Aug 1, 2019
Abstract
Alzheimer's disease (AD) is one of the most common forms of dementia. AD is a chronic syndrome of the central nervous system that causes a decline in cognitive function and language ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed for the treatment of AD, including naturally‑derived inhibitors, synthetic analogues and hybrids. Currently, the available drugs for AD are predominantly...
Paper Details
Title
Cholinesterase inhibitors as Alzheimer's therapeutics (Review).
DOI
Published Date
Aug 1, 2019
Journal
Volume
20
Issue
2
Pages
1479 - 1487
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.